The DOI matches its Crossref record; 304 of the 308 references it cites were found in a registry or an index.
Pathophysiology of circulating xanthine oxidoreductase: New emerging roles for a multi-tasking enzyme
Open accessAbstract
The enzyme xanthine oxidoreductase (XOR) catalyses the last step of purine degradation in the highest uricotelic primates as a rate-limiting enzyme in nucleic acid catabolism. Although XOR has been studied for more than a century, this enzyme continues to arouse interest because its involvement in many pathological conditions is not completely known. XOR is highly evolutionarily conserved; moreover, its activity is very versatile and tuneable at multiple-levels and generates both oxidant and anti-oxidant products. This review covers the basic information on XOR biology that is essential to understand its enzymatic role in human pathophysiology and provides a comprehensive catalogue of the experimental and human pathologies associated with increased serum XOR levels. The production of radical species by XOR oxidase activity has been intensively studied and evaluated in recent decades in conjunction with the cytotoxic consequences and tissue injuries of various pathological conditions. More recently, a role has emerged for the activity of endothelium-bound enzymes in inducing the vascular response to oxidative stress, which includes the regulation of pro-inflammatory and pro-thrombotic activities of endothelial cells. The possible physiological functions of circulating XOR and the products of its enzyme activity are presented here together with their implications in cardiovascular and metabolic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The binding of plasma XO to ECs can lead to vascular dysfunction (45, 71, 562, 612, 1010).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [71]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Aoki, N. (2006) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.60142 · Cited by 48 · cited 1×
“as a membrane-associated protein in the secretion of milk lipids during lactation in mice [87,88] (reviewed in [89]).”
BackgroundRetractedOxygen-Derived Free Radicals in Postischemic Tissue Injury
Epstein, F. H., & McCord, J. M. (1985) · New England Journal of Medicine · doi:10.1056/nejm198501173120305 · Cited by 5,399 · cited 2×
“In particular, attention has been focused on the role of XOR-derived ROS in the pathogenesis of tissue lesions induced by reperfusion after ischaemia (reviewed in [16,146]).”
BackgroundEndothelial dysfunction in cardiovascular diseases: the role of oxidant stress
Cai, H., & Harrison, D. G. (2000) · Circulation Research · doi:10.1161/01.res.87.10.840 · Cited by 3,839
Ames, B. N., Cathcart, R., Schwiers, E., & Hochstein, P. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.11.6858 · Cited by 2,915 · cited 1×
“advantage for uricotelic primates over ureotelic mammals [36] (reviewed in [37]).”
BackgroundUric Acid and Cardiovascular Risk
Feig, D. I., Kang, D., & Johnson, R. J. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0800885 · Cited by 2,467
Elevated Uric Acid Increases Blood Pressure in the Rat by a Novel Crystal-Independent Mechanism
Mazzali, M., Hughes, J., Kim, Y.-G., Jefferson, J. A., Kang, D., GORDON, K. L., Lan, H. Y., Kivlighn, S. D., & Johnson, R. J. (2001) · Hypertension · doi:10.1161/hy1101.092839 · Cited by 1,298 · cited 1×
“either by inhibiting XOR activity, which produces uric acid, or by inducing uricosuria, which eliminates uric acid [281,282].”
BackgroundPacher, P., Nivorozhkin, A., & Szabó, C. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.1.6 · Cited by 1,218 · cited 3×
“same purpose, the XOR inhibitor allopurinol has been used in many experimental and clinical studies (reviewed in [150]).”
BackgroundInfluentialThe Reduction of Cytochrome c by Milk Xanthine Oxidase
McCord, J. M., & Fridovich, I. (1968) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)91929-0 · Cited by 1,196 · cited 1×
“When oxygen is the electron acceptor, the reaction occurs via a one-electron reduction, producing superoxide ions [13], and a two-electron reduction, generating hydrogen peroxide (reviewed in [12]).”
BackgroundA causal role for uric acid in fructose-induced metabolic syndrome
Nakagawa, T., Hu, H., Zharikov, S. I., Tuttle, K. R., Short, R., Glushakova, O. Y., Ouyang, X., Feig, D. I., Block, E. R., Herrera-Acosta, J., et al. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00140.2005 · Cited by 1,111 · cited 1×
“prevented with allopurinol or reversed with a uricosuric agent [284] (reviewed in [272,285]).”
BackgroundJohnson, R. J., Segal, M. S., Sautin, Y., Nakagawa, T., Feig, D. I., Kang, D.-H., Gersch, M. S., Benner, S., & Sánchez-Lozada, L. G. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.4.899 · Cited by 1,075
Reactive species mechanisms of cellular hypoxia-reoxygenation injury
Li, C., & Jackson, R. M. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00112.2001 · Cited by 1,058 · cited 2×
“In cells, hypoxia is able to induce numerousmetabolic alterations and the activation of transcriptional factors, including hypoxia-inducible factor-1 (HIF-1), nuclear factor-κB (NF-κB), and protein kinases, such as mitogenactivated protein kinase (MAPK) (reviewed in [110]).”
BackgroundUric Acid and Oxidative Stress
Glantzounis, G. K., Tsimoyiannis, E., Kappas, A. M., & Galaris, D. (2005) · Current Pharmaceutical Design · doi:10.2174/138161205774913255 · Cited by 1,043 · cited 1×
“However, it should be noted that the final product of purine catabolism, uric acid, has an important role in vivo as an antioxidant (reviewed in [35]).”
BackgroundUric Acid: The Oxidant-Antioxidant Paradox
Sautin, Y. Y., & Johnson, R. J. (2008) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770802138558 · Cited by 1,029 · cited 1×
“inflammatory effects, the latter function being exerted by the products of uric acid oxidation in the presence of peroxide [269].”
BackgroundFeig, D., Soletsky, B., & Johnson, R. J. (2008) · Journal of the American Medical Association (JAMA) · doi:10.1001/jama.300.8.924 · Cited by 936 · cited 1×
“Moreover, allopurinol treatment resulted in blood pressure reduction in adolescents with newly diagnosed hypertension [288], although it is not clear if the benefit was due to XOR activity inhibition, uricaemia reduction, or the ROS scavenging activity of allopurinol (reviewed in [289]).”
BackgroundBerry, C. E., & Hare, J. M. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.055913 · Cited by 925 · cited 2×
“advantage for uricotelic primates over ureotelic mammals [36] (reviewed in [37]).”
BackgroundRole of xanthine oxidase and granulocytes in ischemia-reperfusion injury
Granger, D. N. (1988) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1988.255.6.h1269 · Cited by 818
Structure and function of xanthine oxidoreductase: where are we now?
Harrison, R. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00956-5 · Cited by 807
Does superoxide underlie the pathogenesis of hypertension?
Nakazono, K., Watanabe, N., Matsuno, K., Sasaki, J., Sato, T., & Inoue, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.10045 · Cited by 746
The Regulation of Rat Liver Xanthine Oxidase
Stirpe, F., Corte, E. D., & Lorenzoni, E. (1969) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36428-1 · Cited by 733
Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression.
Rao, G. N., & Berk, B. C. (1992) · Circulation Research · doi:10.1161/01.res.70.3.593 · Cited by 649 · cited 1×
“In addition to cytotoxicity and tissue damage, XOR-generated ROS are responsible for many biological activities, including iron mobilisation from ferritin in the liver [17], iron absorption in the intestinal mucosal [18], and the induction of proliferation [19–21] as well as defence against infectious diseases by cont…”
BackgroundXanthine oxidase: biochemistry, distribution and physiology.
Parks, D. A., & Granger, D. N. (1986) · PubMed · Cited by 638
Petrone, W. F., English, D. K., Wong, K. L., & McCord, J. M. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.2.1159 · Cited by 616 · cited 1×
“Indeed, these oxidantsmay play a role in the cytotoxic activity of phagocytes either directly [22] by activating a chemotactic factor [23] and pro-collagenase [24], by increasing the adhesion of leukocytes [25] and cytokine production by monocytes [26], or by inducing the accumulation of leukocytes inmicrovasculature…”
BackgroundRole of Oxidative Stress in Myocardial Hypertrophy and Failure
Sawyer, D. B., Siwik, D. A., Xiao, L., Pimentel, D. R., Singh, K., & Colucci, W. S. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2002.1526 · Cited by 567 · cited 2×
“present at high levels (reviewed in [243,267]).”
BackgroundDoehner, W., Schoene, N., Rauchhaus, M., Leyva‐Leon, F., Pavitt, D. V., Reaveley, D. A., Schuler, G. C., Coats, A. J. S., Anker, S. D., & Hambrecht, R. (2002) · Circulation · doi:10.1161/01.cir.0000017502.58595.ed · Cited by 565
Allopurinol Improves Endothelial Dysfunction in Chronic Heart Failure
Farquharson, C. A. J., Butler, R., Hill, A., Belch, J. J. F., & Struthers, A. D. (2002) · Circulation · doi:10.1161/01.cir.0000022140.61460.1d · Cited by 504 · cited 1×
“capacity and blood flow locally and systemically in hyperuricaemic patients with chronic heart failure [258,259] and in patientswith coronary”
BackgroundXanthine oxidase and xanthine dehydrogenase
Hille, R., & Nishino, T. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.11.7649415 · Cited by 445
Corte, E. D., & Stirpe, F. (1972) · Biochemical Journal · doi:10.1042/bj1260739 · Cited by 437
Allopurinol Improves Myocardial Efficiency in Patients With Idiopathic Dilated Cardiomyopathy
Cappola, T. P., Kass, D. A., Nelson, G. S., Berger, R. D., Rosas, G. O., Kobeissi, Z. A., Marbán, E., & Hare, J. M. (2001) · Circulation · doi:10.1161/hc4501.098928 · Cited by 436 · cited 2×
“enzyme activity by allopurinol administration resulted in a significant improvement in myocardial efficiency [151].”
BackgroundOxygen Radicals in Influenza-Induced Pathogenesis and Treatment with Pyran Polymer-Conjugated SOD
Oda, T., Akaike, T., Hamamoto, T., Suzuki, F., Hirano, T., & Maeda, H. (1989) · Science · doi:10.1126/science.2543070 · Cited by 418 · cited 1×
“with inflammation, as reported in mice treated with the IFN inducer [90] or infected with influenza virus [170–172], in rats after thermal”
BackgroundNishino, T., Okamoto, K., Eger, B. T., PAI, E. F., & Nishino, T. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06489.x · Cited by 397 · cited 3×
“and slow (SH**) reacting (reviewed in [67]).”
BackgroundInfluentialImpact of Oxypurinol in Patients With Symptomatic Heart Failure
Hare, J. M., Mangal, B., Brown, J., Fisher, C., Freudenberger, R., Colucci, W. S., Mann, D. L., Liu, P., Givertz, M. M., & Schwarz, R. P. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.01.068 · Cited by 392
Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease
Aslan, M., Ryan, T. M., Adler, B., Townes, T. M., Parks, D. A., Thompson, J. A., Tousson, A., Gladwin, M. T., Patel, R. P., Tarpey, M. M., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221292098 · Cited by 391 · cited 1×
“intrahepatic hypoxia/reoxygenation, which can induce XOR release into the circulation from an injured liver [216].”
BackgroundXanthine Oxidase Is Involved in Free Radical Production in Type 1 Diabetes
Desco, C., Asensi, M. A., Márquez, R., Martínez-Valls, J. F., Vento, M., Pallardó, F. V., Sastre, J., & Viña, J. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1118 · Cited by 391 · cited 1×
“skin injury [173–175], in cattle receiving LPS [176], in hypercholesterolaemic rabbits [177], in streptozotocin-induced diabetic rats [178] and”
BackgroundBrain injury, edema, and vascular permeability changes induced by oxygen‐derived free radicals
Chan, P. H., Schmidley, J. W., Fishman, R. A., & Longar, S. (1984) · Neurology · doi:10.1212/wnl.34.3.315 · Cited by 382
White, C. R., Darley-Usmar, V, Berrington, W. R., McAdams, M., Gore, J. Z., Thompson, J. A., Parks, D. A., Tarpey, M. M., & Freeman, B. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8745 · Cited by 367
Mendel, R. R., & Bittner, F. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.03.013 · Cited by 365 · cited 2×
“in vivo by the XORmolybdenum cofactor sulphurase via the reinsertion of a sulphur atom at the active site (reviewed in [100]).”
BackgroundRemote Ischemic Preconditioning: A Novel Protective Method From Ischemia Reperfusion Injury—A Review
Tapuria, N., Kumar, Y., Habib, M. M., Abu‐Amara, M., Seifalian, A. M., & Davidson, B. R. (2008) · Journal of Surgical Research · doi:10.1016/j.jss.2007.12.747 · Cited by 359 · cited 1×
“in distant organs, whereas high levels of ROS may activate a cascade of ischaemia/reperfusion injury (reviewed in [242]).”
BackgroundConversion of xanthine dehydrogenase to oxidase in ischemic rat tissues.
Engerson, T. D., McKelvey, T. G., Rhyne, D. B., Boggio, E. B., Snyder, S. J., & Jones, H. P. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112990 · Cited by 350
A comparison of the specificities of xanthine oxidase and aldehyde oxidase
Krenitsky, T. A., Neil, S. M., Elion, G. B., & Hitchings, G. H. (1972) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(72)90078-1 · Cited by 341 · cited 1×
“compounds [7] (reviewed in [8]), and retinol [9].”
BackgroundAkaike, T., Ando, M., Oda, T., Doi, T., Ijiri, S., Araki, S., & Maeda, H. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114499 · Cited by 333
FRUCTOSE-INDUCED HYPERURICÆMIA
Stirpe, F., Corte, E. D., Bonetti, E., Abbondanza, A., Abbati, A., & Stefano, F. D. (1970) · The Lancet · doi:10.1016/s0140-6736(70)92269-5 · Cited by 331
Redox signaling in cardiac myocytes
Santos, C. X. C., Anilkumar, N. P., Zhang, M., Brewer, A. C., & Shah, A. M. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.01.003 · Cited by 325 · cited 3×
“6b), including detrimental effects, such as pathological hypertrophy or apoptosis, and protective effects, such as adaptive hypertrophy and angiogenesis (reviewed in [243]).”
BackgroundSignificance of xanthine oxidase in capillary endothelial cells.
Ed, J., Bruder, G., & Heid, H. (1986) · PubMed · Cited by 325
Conversion of xanthine dehydrogenase to oxidase in ischemic rat intestine: a reevaluation
Parks, D. A., Williams, T. K., & Beckman, J. S. (1988) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1988.254.5.g768 · Cited by 282 · cited 1×
“Additionally, reversible or irreversible XDH/XO conversion was observed in a variety of hypoxic/ischaemic conditions in rat tissues, including the liver, kidney, heart, and lung [138], liver and kidney [139], intestine [140], liver [141], and brain [106,142–144].”
BackgroundUric acid and oxidative stress: Relative impact on cardiovascular risk
Strazzullo, P., & Puig, J. G. (2007) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.02.011 · Cited by 281
Akyol, Ö., Herken, H., Uz, E., Fadıllıoğlu, E., Ünal, S., Söğüt, S., Özyurt, H., & SAVAS, H. A. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00220-8 · Cited by 280
The species distribution of xanthine oxidase
Al-Khalidi, U. A. S., & Chaglassian, T. (1965) · Biochemical Journal · doi:10.1042/bj0970318 · Cited by 272 · cited 1×
“variation; in particular, a wide range of activity levels has been reported in biological fluids, such as blood [46] (reviewed in [47]) and milk (reviewed in [39]).”
BackgroundBinding of Xanthine Oxidase to Vascular Endothelium
Houston, M., Estévez, Á. G., Chumley, P. H., Aslan, M., Marklund, S. L., Parks, D. A., & Freeman, B. Α. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.8.4985 · Cited by 271 · cited 3×
“Finally, endothelium-bound XOR activity was also able to inhibit endothelial NO production, thus impairing vasodilatory reaction [234].”
BackgroundInfluentialCharacterization of free radical generation by xanthine oxidase
Kuppusamy, P., & Zweier, J. L. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)81740-9 · Cited by 263 · cited 1×
“cal and pathological conditions due to the formation of hydroxyl radicals in the presence of iron via the Haber–Weiss reaction [14], as is the case in acute iron intoxication [15].”
BackgroundReperfusion Injury as the Mechanism of Brain Damage after Perinatal Asphyxia
Fellman, V., & Raivio, K. O. (1997) · Pediatric Research · doi:10.1203/00006450-199705000-00001 · Cited by 255 · cited 1×
“investigated in animal models by pre-treatment with tungsten, which inactivates XOR, to prevent organ damage (reviewed in [149]).”
BackgroundEkelund, U. E. G., Harrison, R. W., Shokek, O., Thakkar, R. N., Tunin, R. S., Senzaki, H., Kass, D. A., Marbán, E., & Hare, J. M. (1999) · Circulation Research · doi:10.1161/01.res.85.5.437 · Cited by 239 · cited 1×
“in dogswith pacing-induced heart failure [251].”
Role of oxygen free radicals in shock, ischemia, and organ preservation.
Parks, D. A., Bulkley, G. B., & Granger, D. N. (1983) · PubMed · Cited by 236
Galli, A., Svegliati‐Baroni, G., Ceni, E., Milani, S., Ridolfi, F., Salzano, R., Tarocchi, M., Grappone, C., Pellegrini, G., Benedetti, A., et al. (2005) · Hepatology · doi:10.1002/hep.20683 · Cited by 235 · cited 1×
“In addition to cytotoxicity and tissue damage, XOR-generated ROS are responsible for many biological activities, including iron mobilisation from ferritin in the liver [17], iron absorption in the intestinal mucosal [18], and the induction of proliferation [19–21] as well as defence against infectious diseases by cont…”
BackgroundRoles of histamine, complement and xanthine oxidase in thermal injury of skin.
Friedl, H. P., Till, G. O., Trentz, O., & Ward, P. A. (1989) · PubMed Central · Cited by 234
Meneshian, A., & Bulkley, G. B. (2002) · Microcirculation · doi:10.1038/sj.mn.7800136 · Cited by 225 · cited 1×
“producing form of XOR in vivo could imply its well-studied pathological role of inducing tissue damage and the physiological function of triggering a microvascular inflammatory response through an oxidantmediated signal transduction (reviewed in [246]).”
BackgroundFree radical-mediated reperfusion injury: a selective review.
Bulkley, G. B. (1987) · PubMed · Cited by 220
Mediator‐induced activation of xanthine oxidase in endothelial cells
Friedl, H. P., Till, G. O., Ryan, U. S., & Ward, P. A. (1989) · The FASEB Journal · doi:10.1096/fasebj.3.13.2806779 · Cited by 218 · cited 1×
“stimulation with C5a, TNF, a chemotactic N-formyl peptide [126] or activated neutrophils [127,128]; kainic acid [60] or glutamate neurotoxicity [129]; ricin hepatotoxicity [130]; in a rat model of nephropathy [131]; ultraviolet B radiation [132]; irradiation with gamma rays [133]; hepatocellular injury induced by iron…”
BackgroundGranger, D. N. (1999) · Microcirculation · doi:10.1111/j.1549-8719.1999.tb00099.x · Cited by 218 · cited 4×
“Indeed, the inhibition of NO production by vascular XOR activity could explain how XOR released into plasma during diverse pathological processes may alter vascular functions via oxidative mechanisms by reducing vasodilatory responses (reviewed in [244]).”
BackgroundInfluentialGhosh, S. M., Kapil, V., Fuentes-Calvo, I., Bubb, K. J., Pearl, V., Milsom, A. B., Khambata, R., Maleki-Toyserkani, S., Yousuf, M., Benjamin, N., et al. (2013) · Hypertension · doi:10.1161/hypertensionaha.111.00933 · Cited by 218 · cited 1×
“Thus, allopurinol treatment could suppress the blood pressurelowering effects of dietary nitrates [302].”
BackgroundVascular Dysfunction in Ischemia-Reperfusion Injury
Seal, J. B., & Gewertz, B. L. (2005) · Annals of Vascular Surgery · doi:10.1007/s10016-005-4616-7 · Cited by 217 · cited 1×
“5b) (reviewed in [245]).”
Binding of human xanthine oxidase to sulphated glycosaminoglycans on the endothelial-cell surface
Adachi, T., Fukushima, T., Usami, Y., & Hirano, K. (1993) · Biochemical Journal · doi:10.1042/bj2890523 · Cited by 213 · cited 1×
“the ability to stick to vascular cells because it binds to sulphated glycosaminoglycans on the endothelial cell surface [233].”
BackgroundVorbach, C., Scriven, A., & Capecchi, M. R. (2002) · Genes & Development · doi:10.1101/gad.1032702 · Cited by 211 · cited 1×
“as a membrane-associated protein in the secretion of milk lipids during lactation in mice [87,88] (reviewed in [89]).”
BackgroundLandmesser, U., Spiekermann, S., Preuss, C., Sorrentino, S., Fischer, D., Manes, C., Mueller, M., & Drexler, H. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000258415.32883.bf · Cited by 210 · cited 1×
“In patients with coronary disease, treatment with the AT1-receptor blocker losartan reduced endothelium-bound XOR activity and endothelial dysfunction [265].”
BackgroundSaavedra, W. F., Paolocci, N., John, M. E. S., Skaf, M. W., Stewart, G. C., Xie, J.-S., Harrison, R. W., Zeichner, J., Mudrick, D. W., Marbán, E., et al. (2002) · Circulation Research · doi:10.1161/hh0302.104531 · Cited by 196 · cited 1×
“resulted in an imbalance between XOR activity and NOproduction, contributing to mechanoenergetic uncoupling in heart failure [252].”
BackgroundXanthine dehydrogenase/xanthine oxidase and oxidative stress
Chung, H. Y., Baek, B. S., Song, S. H., Kim, M. S., Huh, J. I., Shim, K. H., Kim, K. W., & Lee, K. H. (1997) · AGE · doi:10.1007/s11357-997-0012-2 · Cited by 194 · cited 1×
“activity (reviewed in [39,43]).”
Ioachimescu, A. G., Brennan, D. M., Hoar, B. M., Hazen, S. L., & Hoogwerf, B. J. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23121 · Cited by 194 · cited 1×
“cular disease [276].”
Role of Xanthine Oxidoreductase as an Antimicrobial Agent
Martin, H. M., Hancock, J. T., Salisbury, V. C., & Harrison, R. (2004) · Infection and Immunity · doi:10.1128/iai.72.9.4933-4939.2004 · Cited by 192 · cited 1×
“The anti-microbial activity of XOR has been exhaustively reviewed in [33].”
BackgroundXanthine oxidase type D (dehydrogenase) in the intestine and other organs of the rat
Battelli, M. G., Corte, E. D., & Stirpe, F. (1972) · Biochemical Journal · doi:10.1042/bj1260747 · Cited by 192 · cited 1×
“(reviewed in [3]) until almost half a century ago, when mammalian XOR was shown to be a dehydrogenase in its native state [40,41].”
BackgroundSelf-citationCirculating xanthine oxidase: potential mediator of ischemic injury
Yokoyama, Y., Beckman, J. S., Beckman, T. K., Wheat, J. K., Cash, T., Freeman, B. Α., & Parks, D. A. (1990) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1990.258.4.g564 · Cited by 188 · cited 2×
“perfusate was similar to the paralleled decrease in endogenous tissue enzyme [192].”
BackgroundHypoxia, reactive oxygen, and cell injury
de GROOT, H., & Littauer, A. (1989) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(89)90047-6 · Cited by 176
Mammalian peroxisomes and reactive oxygen species
Schrader, M., & Fahimi, H. D. (2004) · Histochemistry and Cell Biology · doi:10.1007/s00418-004-0673-1 · Cited by 175
NADH Oxidase Activity of Human Xanthine Oxidoreductase
Sanders, S. A., Eisenthal, R., & Harrison, R. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00541.x · Cited by 170 · cited 2×
“The bactericidal activity of XOR may be potentiated either by the possibility to act as an NADH oxidase [29–31] or by the ability to produce peroxynitrite [32].”
BackgroundCellular distribution, metabolism and regulation of the xanthine oxidoreductase enzyme system
Pritsos, C. A. (2000) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(00)00203-9 · Cited by 167
Dawson, J., & Walters, J. (2006) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02785.x · Cited by 167 · cited 2×
“indicated that uric acid reductionmay contribute to the reduction of risk (reviewed in [277,278]).”
BackgroundUric Acid Predicts Clinical Outcomes in Heart Failure
Hare, J. M., & Johnson, R. J. (2003) · Circulation · doi:10.1161/01.cir.0000066420.36123.35 · Cited by 165 · cited 2×
“infarction, and cardiovascular death (reviewed in [273,274]).”
BackgroundHiggins, P., Dawson, J., Lees, K. R., McArthur, K., Quinn, T. J., & Walters, M. R. (2012) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2011.00277.x · Cited by 164
Oxidative Stress and Vascular Function: Implications for Pharmacologic Treatments
Weseler, A. R., & Bast, A. (2010) · Current Hypertension Reports · doi:10.1007/s11906-010-0103-9 · Cited by 161 · cited 1×
“The main molecular sources of such oxidants in endothelial cells have been identified in NAD(P)H oxidase, xanthine oxidase, and NO synthase, which are involved in the dysregulation of the vascular redox environment that is associated with impaired vascular function and cardiovascular diseases (reviewed in [290]).”
BackgroundGonzález, D. R., Treuer, A. V., Castellanos, J. A., Dulce, R. A., & Hare, J. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.154948 · Cited by 160 · cited 2×
“cate that nitroso-redox disequilibrium at the sarcoplasmic reticulum level is due to oxidative stress, which is possibly dependent on XOR up-regulation [266].”
BackgroundUmezawa, K., Akaike, T., Fujii, S., Suga, M., Setoguchi, K., Ozawa, A., & Maeda, H. (1997) · Infection and Immunity · doi:10.1128/iai.65.7.2932-2940.1997 · Cited by 154 · cited 1×
“The inhibition of these enzyme activities resulted in the exacerbation of the infection, indicating their importance as anti-microbial leukocyte defences [98].”
BackgroundMcKelvey, T. G., Höllwarth, M. E., Granger, D. N., Engerson, T. D., Landler, U., & Jones, H. P. (1988) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1988.254.5.g753 · Cited by 151 · cited 1×
“Additionally, reversible or irreversible XDH/XO conversion was observed in a variety of hypoxic/ischaemic conditions in rat tissues, including the liver, kidney, heart, and lung [138], liver and kidney [139], intestine [140], liver [141], and brain [106,142–144].”
BackgroundWatts, R. W. E., Watts, J. E. M., & Seegmiller, J. E. (1965) · PubMed · Cited by 151
Ichida, K., Matsumura, T., Sakuma, R., Hosoya, T., & Nishino, T. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4719 · Cited by 151 · cited 1×
“, XOR deficiency [104].”
Phan, S. H., Gannon, D. E., Varani, J., Ryan, U. S., & Ward, P. A. (1989) · PubMed Central · Cited by 147
Ischemia-reperfusion in humans. Appearance of xanthine oxidase activity.
Friedl, H. P., Smith, D. J., Till, G. O., Thomson, P. D., Louis, D. S., & Ward, P. A. (1990) · Europe PMC (PubMed Central) · Cited by 145
Pfeffer, K. D., Huecksteadt, T. P., & Hoidal, J. R. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.4.1789 · Cited by 145
Ichida, K., Amaya, Y., Nöda, K., Shinsei, M., Hosoya, T., Sakai, O., Shimizu, N., & Takeshi, N. (1993) · Gene · doi:10.1016/0378-1119(93)90652-j · Cited by 144
Uric Acid and Hypertension: Cause or Effect?
Mazzali, M., Kanbay, M., Segal, M. S., Shafiu, M., Jalal, D. I., Feig, D. I., & Johnson, R. J. (2010) · Current Rheumatology Reports · doi:10.1007/s11926-010-0094-1 · Cited by 142
Battelli, M. G., Lorenzoni, E., & Stirpe, F. (1973) · Biochemical Journal · doi:10.1042/bj1310191 · Cited by 141
Self-citationDehydrogenase conversion to oxidase and lipid peroxidation in brain after carbon monoxide poisoning
Thom, S. R. (1992) · Journal of Applied Physiology · doi:10.1152/jappl.1992.73.4.1584 · Cited by 140 · cited 1×
“Additionally, reversible or irreversible XDH/XO conversion was observed in a variety of hypoxic/ischaemic conditions in rat tissues, including the liver, kidney, heart, and lung [138], liver and kidney [139], intestine [140], liver [141], and brain [106,142–144].”
BackgroundBaker, J. E., Su, J., Fu, X., Hsu, A., Gross, G. J., Tweddell, J. S., & Hogg, N. (2007) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2007.07.057 · Cited by 137
Dupont, G. P., Huecksteadt, T. P., Marshall, B. C., Ryan, U. S., Michael, J. R., & Hoidal, J. R. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115563 · Cited by 136 · cited 1×
“Additionally, XOR activity was up-regulated by IFNγ in rat lung endothelial cells [93].”
BackgroundXanthine oxidase activity in the circulation of rats following hemorrhagic shock
Tan, S., Yokoyama, Y., Dickens, E., Cash, T., Freeman, B. Α., & Parks, D. A. (1993) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(93)90040-2 · Cited by 134 · cited 1×
“to vascular lining was shown to be heparin reversible in studies with cultured endothelial cells [189].”
BackgroundMcManaman, J. L., Palmer, C. A., Wright, R. M., & Neville, M. C. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2002.027185 · Cited by 132 · cited 1×
“until lactation followed by decreasing levels with mammary involution [84].”
BackgroundTerada, L. S., Dormish, J. J., Shanley, P. F., Leff, J. A., Anderson, B. O., & Repine, J. E. (1992) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1992.263.3.l394 · Cited by 130 · cited 2×
“elevation after artery ligation in cats [181], rabbits [182–186], and rats [27,157,187,188] as well as after haemorrhagic shock in mice [26] and”
BackgroundAtlante, A., Gagliardi, S., Minervini, G. M., Ciotti, M. T., Marra, E., & Calissano, P. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68052038.x · Cited by 126
Enhanced Expression and Activity of Xanthine Oxidoreductase in the Failing Heart
de Jong, J. W., Schoemaker, R. G., de Jonge, R., Bernocchi, P., Keijzer, E., Harrison, R., Sharma, H. S., & Ceconi, C. (2000) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2000.1240 · Cited by 120
Sánchez‐Lozada, L. G., Tapia, E., Soto, V., Ávila-Casado, C., Franco, M., Zhao, L., & Johnson, R. J. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm783 · Cited by 120 · cited 2×
“sion, and hypertriglyceridaemia and prevented an increase in fasting plasma insulin in rats with fructose-induced metabolic syndrome [282].”
BackgroundTerao, M., Cazzaniga, G., Ghezzi, P., Bianchi, M., Francesco Falciani, B., Perani, P., & Garattini, E. (1992) · Biochemical Journal · doi:10.1042/bj2830863 · Cited by 117
Cingolani, H. E., Plastino, J. A. M., Escudero, E. M., Mangal, B., Brown, J., & Pérez, N. G. (2006) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2006.05.005 · Cited by 117 · cited 1×
“The treatment significantly improved the left ventricular ejection fraction only in 21 patients who exhibited this initial parameter lower or equal to 40% [261].”
BackgroundHuman liver xanthine oxidase: Nature and extent of individual variation
Guerciolini, R., Szumlanski, C. L., & Weinshilboum, R. M. (1991) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1991.205 · Cited by 116 · cited 1×
“Based on its levels of mRNA and protein expression, the highest activity levels of human XOR are present in the intestine [50,51] and liver [52–54], while a very low activity has been detected in other human organs [55,56].”
BackgroundOrgan distribution and molecular forms of human xanthine dehydrogenase/xanthine oxidase protein.
Sarnesto, A., Linder, N., & Raivio, K. O. (1996) · PubMed · Cited by 114
Confirmation of Superoxide Generation via Xanthine Oxidase in Streptozotocin-induced Diabetic Mice
Matsumoto, S., Koshiishi, I., Inoguchi, T., Nawata, H., & Utsumi, H. (2003) · Free Radical Research · doi:10.1080/1071576031000107344 · Cited by 112 · cited 1×
“mice [179], and in fructose-induced hyperuricaemic mice [180].”
BackgroundFernández, L., Heredia, N., Grande, L., Gómez, G., Rimola, A., Marco, A. J., Gelpı́, E., Roselló‐Catafau, J., & Peralta, C. (2002) · Hepatology · doi:10.1053/jhep.2002.34616 · Cited by 112 · cited 1×
“tion of xanthine and XOR to pre-conditioned rats [158].”
BackgroundZhang, Z., Blake, D. R., Stevens, C. R., Kanuler, J. M., Ward, P. G., Symons, M. C. R., Benboubetra, M., & Harrison, R. (1998) · Free Radical Research · doi:10.3109/10715769809065801 · Cited by 110 · cited 1×
“The bactericidal activity of XOR may be potentiated either by the possibility to act as an NADH oxidase [29–31] or by the ability to produce peroxynitrite [32].”
BackgroundPeralta, C., Bulbena, O., Xaus, C., Prats, N., Cutrìn, J. C., Poli, G., Gelpı́, E., & Roselló‐Catafau, J. (2002) · Transplantation · doi:10.1097/00007890-200204270-00004 · Cited by 110 · cited 2×
“elevation after artery ligation in cats [181], rabbits [182–186], and rats [27,157,187,188] as well as after haemorrhagic shock in mice [26] and”
BackgroundRole of oxygen free radicals in shock, ischemia, and organ preservation
Bingham, H. G. (1984) · Plastic & Reconstructive Surgery · doi:10.1097/00006534-198408000-00086 · Cited by 109
Hassoun, P. M., Yu, F., Côté, C., Zulueta, J. J., Sawhney, R., Skinner, K. A., Skinner, H. B., Parks, D. A., & Lanzillo, J. J. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.1.9709116 · Cited by 108
Chen, L., Lan, Z., Lin, Q., Mi, X., He, Y., Wei, L., Lin, Y., Zhang, Y., & Deng, X. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.10.037 · Cited by 106 · cited 2×
“XOR activity inhibition with polydatin reduced enzyme activity in serum and renal injury by attenuating hyperuricaemia and related inflammatory responses in fructose-induced urate nephropathic mice [180].”
BackgroundMitropoulos, D., Deliconstantinos, G., Zervas, A., Villiotou, V., Dimopoulos, C., & Stavrides, J. C. (1996) · The Journal of Urology · doi:10.1016/s0022-5347(01)65403-x · Cited by 105 · cited 1×
“due to reduced blood flow in the dilated varicocele vein [219].”
BackgroundEffects of Oxidative Stress on Immunosuppression Induced by Selenium Deficiency in Chickens
Zhang, Z., Wang, Q., Zhang, J., Li, S., Wang, X., & Xu, S. (2012) · Biological Trace Element Research · doi:10.1007/s12011-012-9439-0 · Cited by 103 · cited 1×
“In contrast, a lack of vitamin E, selenium or folic acid or a lipid-enriched diet increased liver XOR mRNA and protein expression [81,82].”
BackgroundBrass, C. A., Narciso, J. P., & Gollan, J. L. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115013 · Cited by 101
Weinbroum, A. A., Nielsen, V. G., Tan, S., Gelman, S., Matalon, S., Skinner, K. A., Bradley, E. L., & Parks, D. A. (1995) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1995.268.6.g988 · Cited by 101 · cited 2×
“leased from the liver after ischaemia/reperfusion, in which XOR activity decreased in hepatic tissue and increased in the effluent perfusate [193].”
BackgroundIntestinal mucosal alterations in experimental cirrhosis in the rat: Role of oxygen free radicals
Ramachandran, A., Ramamoorthy, P., Thomas, S., Reddy, J. B., Pulimood, A. B., & Balasubramanian, K. A. (2002) · Hepatology · doi:10.1053/jhep.2002.31656 · Cited by 100 · cited 1×
“cirrhotic rats [136]; and in rat brain following in vivo acute ammonia intoxication [137].”
BackgroundXanthine oxidoreductase in respiratory and cardiovascular disorders
Boueiz, A. R., Damarla, M., & Hassoun, P. M. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00007.2008 · Cited by 100 · cited 2×
“Therefore, it is not simple to identify the specific role of these two enzymes in cardiovascular diseases (reviewed in [292]).”
BackgroundBaldus, S. E., Köster, R., Chumley, P. H., Heitzer, T. A., Rudolph, V., Ostad, M. A., Warnholtz, A., Staude, H.-J., Thuneke, F., Koss, K., et al. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.06.004 · Cited by 100 · cited 1×
“artery disease [260].”
Page, S., POWELL, D., Benboubetra, M., Stevens, C. R., Blake, D. R., Selase, F., Wolstenholme, A. J., & Harrison, R. (1998) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(98)00028-2 · Cited by 98
Serum uric acid and the risk of hypertension and chronic kidney disease
Feig, D. I. (2014) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000033 · Cited by 97 · cited 1×
“by XOR inhibition is not yet demonstrated, although hyperuricaemia has been suggested to cause these pathologies through the downregulation of NO production (reviewed in [300]).”
BackgroundTourniquet-induced Exsanguination in Patients Requiring Lower Limb Surgery
Mathru, M., Dries, D. J., Barnes, L., Tonino, P. M., Sukhani, R., & Rooney, M. W. (1996) · Anesthesiology · doi:10.1097/00000542-199601000-00003 · Cited by 97
The Reaction of Reduced Xanthine Dehydrogenase with Molecular Oxygen
Harris, C. M., & Massey, V. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.13.8370 · Cited by 96
Oxidation of circulating proteins in alcoholics: role of acetaldehyde and xanthine oxidase
Grattagliano, I., Vendemiale, G., Sabbà, C., Buonamico, P., & Altomare, E. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80324-2 · Cited by 95 · cited 2×
“[200,211,212], and viral infection [61,62,163,200–203].”
BackgroundPlasma xanthine oxidase activity in patients with adult respiratory distress syndrome
Grum, C. M., Ragsdale, R. A., Ketai, L. H., & Simon, R. H. (1987) · Journal of Critical Care · doi:10.1016/0883-9441(87)90116-x · Cited by 94 · cited 1×
“in the plasma of hypoxic subjects, such as patients with adult respiratory distress syndrome [217] and preterm newborn babies [218].”
BackgroundGut Ischemia Mediates Lung Injury by a Xanthine Oxidase-Dependent Neutrophil Mechanism
Koike, K., Moore, F. A., Moore, E. E., Read, R. A., Carl, V. S., & Banerjee, A. N. (1993) · Journal of Surgical Research · doi:10.1006/jsre.1993.1072 · Cited by 91 · cited 1×
“molybdenum-depleted diet abolished these alterations, suggesting a XOR-dependent neutrophil mechanism in the pathogenesis of remote organ injury [236].”
BackgroundNeutrophil Depletion Attenuates Human Intestinal Reperfusion Injury
Sisley, A. C., Desai, T. R., Harig, J. M., & Gewertz, B. L. (1994) · Journal of Surgical Research · doi:10.1006/jsre.1994.1130 · Cited by 91 · cited 1×
“However, the contribution of leukocyte-derived ROS to the pathogenesis of ischaemia/reperfusion damage in vivo was confirmed by the observation that neutrophil depletion attenuates human intestinal reperfusion injury [195].”
BackgroundMuir, S. W., Harrow, C., Dawson, J., Lees, K. R., Weir, C. J., Sattar, N. A., & Walters, M. R. (2008) · Stroke · doi:10.1161/strokeaha.108.519793 · Cited by 90
Mellin, V., Isabelle, M., Oudot, A., Vergely, C., Monteil, C., Meglio, B. D., Henry, J., Dautréaux, B., Rochette, L., Thuillez, C., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi305 · Cited by 90 · cited 1×
“established chronic heart failure [254].”
Wright, R. M., Vaitaitis, G. M., Wilson, C., Repine, T. B., Terada, L. S., & Repine, J. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.22.10690 · Cited by 89
Miesel, R., & Zuber, M. A. (1993) · Inflammation · doi:10.1007/bf00914193 · Cited by 87 · cited 1×
“Elevated XOR levels in human serumwere found in patients with acute and chronic viral hepatitis [61,62,163,200–203], infectious mononucleosis [200], rheumatic and autoimmune diseases [204], pneumonia [205], irritable bowel syndrome [206], schizophrenia [207], and type 2 diabetes [208,209].”
BackgroundKooij, A., Schiller, H. J., Schijns, M., Noorden, C. J. F. V., & Frederiks, W. M. (1994) · Hepatology · doi:10.1002/hep.1840190626 · Cited by 87 · cited 1×
“After being released into plasma, XOR is rapidly converted to the XO form [124,227,232].”
BackgroundSchröder, K., Vecchione, C., Jung, O., Schreiber, J. G., Shiri‐Sverdlov, R., van Gorp, P. J., Busse, R., & Brandes, R. P. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.03.026 · Cited by 86
A re-evaluation of the tissue distribution and physiology of xanthine oxidoreductase
Kooij, A. (1994) · The Histochemical Journal · doi:10.1007/bf00174006 · Cited by 85 · cited 1×
“(reviewed in [3]) until almost half a century ago, when mammalian XOR was shown to be a dehydrogenase in its native state [40,41].”
BackgroundYiğiner, Ö., Özçelik, F., İnanç, T., Aparcı, M., Özmen, N., Cingözbay, B. Y., Kardeşoğlu, E., Süleymanoğlu, S., Şener, G., & Cebeci, B. S. (2007) · Clinical Research in Cardiology · doi:10.1007/s00392-007-0636-3 · Cited by 85 · cited 1×
“In patients with metabolic syndrome and in patients with or at risk of cardiovascular disease, XOR inhibition by means of allopurinol treatment (1) had beneficial effects on endothelial function, thus improving brachial artery flow-mediated dilation and (2) reduced oxidative stress by decreasing myeloperoxidase levels…”
BackgroundLeukocyte-Endothelial Cell Adhesive Interactions: Role of Xanthine Oxidase-Derived Oxidants
Suzuki, M., Grisham, M. B., & Granger, D. N. (1991) · Journal of Leukocyte Biology · doi:10.1002/jlb.50.5.488 · Cited by 85 · cited 1×
“Indeed, these oxidantsmay play a role in the cytotoxic activity of phagocytes either directly [22] by activating a chemotactic factor [23] and pro-collagenase [24], by increasing the adhesion of leukocytes [25] and cytokine production by monocytes [26], or by inducing the accumulation of leukocytes inmicrovasculature…”
BackgroundAthar, M., Elmets, C. A., Bickers, D. R., & Mukhtar, H. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113993 · Cited by 84 · cited 1×
“The increase of ROS-producing enzyme forms has been reported in burn injury [121]; haematoporphyrin derivative-mediated cutaneous photosensitisation [122]; in vivo and in vitro ethanol intoxication [119,123,124]; glutathione depletion [125]; endothelial”
BackgroundXu, X. Y., Hu, X., Lu, Z., Zhang, P., Zhao, L., Wessale, J. L., Bache, R. J., & Chen, Y. (2008) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2008.06.006 · Cited by 81 · cited 1×
“induced left ventricular hypertrophy and dysfunction in mice [298].”
BackgroundIs Ischemic Preconditioning a Useful Strategy in Steatotic Liver Transplantation?
Fernández, L., Carrasco-Chaumel, E., Serafin, A. M., Xaus, C., Grande, L., Rimola, A., Roselló‐Catafau, J., & Peralta, C. (2004) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00447.x · Cited by 80
Regulation of xanthine dehydrogenase and xanthine oxidase activity by hypoxia
Poss, W. B., Huecksteadt, T. P., Panus, P. C., Freeman, B. A., & Hoidal, J. R. (1996) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1996.270.6.l941 · Cited by 79 · cited 1×
“Accordingly, the increased XOR activity observed in response to hypoxia or hypoxia and reoxygenation is due to the post-translational modulation of XOR in cultured bovine aortic endothelial cells [112].”
BackgroundKurosaki, M., Calzi, M. L., Scanziani, E., Garattini, E., & Terao, M. (1995) · Biochemical Journal · doi:10.1042/bj3060225 · Cited by 79 · cited 1×
“, liver and intestine inmice [44] and humans [45].”
BackgroundSchmidt, A., Böhmer, A. E., Antunes, C., Schallenberger, C., Porciúncula, L., Elisabetsky, E., Lara, D., & Souza, D. O. (2008) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00025.x · Cited by 78 · cited 1×
“This is an open access article under anti-nociceptive effect of theXOR inhibitor allopurinol inmice [6].”
BackgroundEnhanced xanthine oxidase activity in mice treated with interferon and interferon inducers
Ghezzi, P., Bianchi, M., Mantovani, A., Spreafico, F., & Salmona, M. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(84)91630-9 · Cited by 78 · cited 2×
“The administration of IFN or IFN-inducers to mice stimulated a marked increase of XOR activity in different organs [90], particularly”
BackgroundSimultaneous Liver and Lung Injury Following Gut Ischemia is Mediated by Xanthine Oxidase
Poggetti, R. S., Moore, F. A., Moore, E. E., KOEIKE, K., & Banerjee, A. M. (1992) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/00005373-199206000-00008 · Cited by 77 · cited 1×
“depleted diet [235].”
Superoxide radical involvement in the pathogenesis of burn shock.
Sáez, J. C., Ward, P. H., Günther, B., & Vivaldi, E. (1984) · PubMed · Cited by 77
Hereditary xanthinuria. Evidence for enhanced hypoxanthine salvage.
Mateos, F., Puig, J. G., Jiménez, M. L., & Fox, I. H. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112893 · Cited by 76
Circulating Xanthine Oxidase in Human Ischemia Reperfusion
Tan, S., Gelman, S., Wheat, J. K., & Parks, D. A. (1995) · Southern Medical Journal · doi:10.1097/00007611-199504000-00021 · Cited by 76 · cited 2×
“reperfusion injury during an aortic cross-clamp procedure, and it was proposed that XOR-induced ROS may explain the damage to the lung or heart observed after ischaemia in human liver and intestine [223].”
BackgroundPurification and partial characterization of xanthine oxidase from human milk
Abadeh, S., Killacky, J., Benboubetra, M., & Harrison, R. (1992) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(92)90157-p · Cited by 75 · cited 4×
“XOR can be found in human milk, although with a lower activity compared with cow milk [57,58].”
BackgroundInfluentialXanthine oxidoreductase activity in human liver disease
Stirpe, F., Ravaioli, M., Battelli, M. G., Musiani, S., & Grazi, G. L. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05925.x · Cited by 74 · cited 1×
“viral infections, including lung [95], brain [96], and liver [97] in mouse pathology and liver in human pathology [54].”
BackgroundSelf-citationNeogi, T., Casella, G., Rekhraj, S., Struthers, A. D., Choi, H. K., & Terkeltaub, R. A. (2011) · Arthritis & Rheumatism · doi:10.1002/art.33369 · Cited by 73 · cited 1×
“infarction, and cardiovascular death (reviewed in [273,274]).”
Hypoxia Regulates Xanthine Dehydrogenase Activity at Pre- and Posttranslational Levels
Terada, L. S., Piermattei, D., Shibao, G. N., McManaman, J. L., & Wright, R. M. (1997) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1997.0367 · Cited by 73 · cited 1×
“The effect of hypoxia in Swiss 3T3 cells has been reported to increase XOR activity without an increase of mRNA levels and followed by an increase ofmRNA levels andXOR activity [106].”
BackgroundAmado, L. C., SALIARIS, A. P., Raju, S., Lehrke, S., John, M. S., XIE, J., Stewart, G. C., Fitton, T. P., Minhas, K. M., & BRAWN, J. (2005) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2005.04.008 · Cited by 72 · cited 1×
“lopurinolwas able to prevent increases in systemic vasoconstriction and was able to improve myocardial contractility [253].”
BackgroundThe Role of Urate and Xanthine Oxidase Inhibitors in Cardiovascular Disease
Casella, G., & Struthers, A. D. (2008) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2007.00029.x · Cited by 72 · cited 1×
“Moreover, allopurinol treatment resulted in blood pressure reduction in adolescents with newly diagnosed hypertension [288], although it is not clear if the benefit was due to XOR activity inhibition, uricaemia reduction, or the ROS scavenging activity of allopurinol (reviewed in [289]).”
BackgroundMilk xanthine oxidoreductase: the first one hundred years
Massey, V., & Harris, C. M. (1997) · Biochemical Society Transactions · doi:10.1042/bst0250750 · Cited by 71 · cited 1×
“XOR has been known since the end of the 1800s and has been the object of a large number of studies, mainly because of its stability and high concentration in a widely available source, bovine milk (for historical reviews, see [2–4]).”
BackgroundA new route to peroxynitrite: a role for xanthine oxidoreductase
GODBER, B. L. J., Doel, J. J., Durgan, J., Eisenthal, R., & Harrison, R. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01639-2 · Cited by 71 · cited 1×
“The bactericidal activity of XOR may be potentiated either by the possibility to act as an NADH oxidase [29–31] or by the ability to produce peroxynitrite [32].”
BackgroundDeliconstantinos, G., Villiotou, V., & Stavrides, J. C. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00110-4 · Cited by 69
Xanthine oxidase inhibitors improve energetics and function after infarction in failing mouse hearts
Naumova, A. V., Chacko, V. P., Ouwerkerk, R., Stull, L. B., Marbán, E., & Weiss, R. G. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00831.2005 · Cited by 68
Peroxisomes and reactive oxygen species, a lasting challenge
Angermüller, S., Islinger, M., & Völkl, A. (2009) · Histochemistry and Cell Biology · doi:10.1007/s00418-009-0563-7 · Cited by 68
Gürel, A. (2013) · Medical Science Monitor · doi:10.12659/msm.889068 · Cited by 68 · cited 1×
“Elevated XOR levels in human serumwere found in patients with acute and chronic viral hepatitis [61,62,163,200–203], infectious mononucleosis [200], rheumatic and autoimmune diseases [204], pneumonia [205], irritable bowel syndrome [206], schizophrenia [207], and type 2 diabetes [208,209].”
BackgroundLung Injury After Hepatoenteric Ischemia-Reperfusion: Role of Xanthine Oxidase
Nielsen, V. G., Tan, S., Weinbroum, A., McCammon, A. T., Samuelson, P. N., Gelman, S., & Parks, D. A. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.5.8912749 · Cited by 67 · cited 1×
“, with liver injury and elevated circulating XOR activity [184,237].”
BackgroundKuppusamy, U. R., Indran, M., & Rokiah, P. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01630.x · Cited by 66 · cited 1×
“Elevated XOR levels in human serumwere found in patients with acute and chronic viral hepatitis [61,62,163,200–203], infectious mononucleosis [200], rheumatic and autoimmune diseases [204], pneumonia [205], irritable bowel syndrome [206], schizophrenia [207], and type 2 diabetes [208,209].”
BackgroundXanthine oxidase activity in the dexamethasone-induced hypertensive rat
Wallwork, C. J., Parks, D. A., & Schmid‐Schönbein, G. W. (2003) · Microvascular Research · doi:10.1016/s0026-2862(03)00019-0 · Cited by 65 · cited 1×
“gene expression, whichmay be regulated by nutritional factors, oxygen tension, steroid hormones [73], phorbol esters [74], regenerative”
BackgroundMononuclear Phagocyte Xanthine Oxidoreductase Contributes to Cytokine-Induced Acute Lung Injury
Wright, R. M., Ginger, L. A., Kosila, N., Elkins, N. D., Essary, B., McManaman, J. L., & Repine, J. E. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0309oc · Cited by 65 · cited 2×
“cells and the production of ROS, peroxynitrites, and cytokines [247,248].”
BackgroundUpregulation of xanthine oxidase by tobacco smoke condensate in pulmonary endothelial cells
Kayyali, U. S., Budhiraja, R., Pennella, C. M., Cooray, S., Lanzillo, J. J., Chalkley, R. G., & Hassoun, P. M. (2003) · Toxicology and Applied Pharmacology · doi:10.1016/s0041-008x(02)00076-5 · Cited by 65 · cited 1×
“Additionally, tobacco smoke condensate up-regulated XOR activity in pulmonary endothelial cells by increasing XOR mRNA expression and XOR gene promoter activity [79].”
BackgroundSerum Xanthine Oxidase in Human Liver Disease
Battelli, M. G., Musiani, S., Valgimigli, M., Gramantieri, L., Tomassoni, F., Bolondi, L., & Stirpe, F. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03700.x · Cited by 65 · cited 1×
“Among human hepatopathies that induce increased plasma XOR levels, we can count massive toxic necrosis [200] as well as the liver damage due to halothane anaesthesia [211], alcoholism [212], or cholestatic disorders [203].”
BackgroundSelf-citationOn the anaerobic and aerobic oxidation of xanthin and hypoxanthin by tissues and by milk
Morgan, E. J., Stewart, C. P., & Hopkins, F. G. (1922) · Proceedings of the Royal Society of London Series B Containing Papers of a Biological Character · doi:10.1098/rspb.1922.0047 · Cited by 64 · cited 1×
“of hypoxanthine to xanthine and the latter to uric acid as the terminal steps of purine degradation in the highest primates [1].”
BackgroundWang, G., Qian, P., Jackson, F. R., Qian, G., & Wu, G. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.08.008 · Cited by 63
Repressed Expression of the Human Xanthine Oxidoreductase Gene
Xu, P., LaVallee, P., & Hoidal, J. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.8.5918 · Cited by 62
Circulating xanthine oxidase and neutrophil activation during human liver transplantation
Pesonen, E., Linder, N., Raivio, K. O., Sarnesto, A., Lapatto, R., Höckerstedt, K., Mäkisalo, H., & Andersson, S. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70321-x · Cited by 61 · cited 1×
“Elevated plasma concentrations of XOR were observed during reperfusion after liver transplantation compared with preoperative levels [226].”
BackgroundPence, B. C., & Reiners, J. J. (1987) · PubMed · Cited by 61
Sulfhydryl oxidase-catalyzed conversion of xanthine dehydrogenase to xanthine oxidase
Clare, D. A., Blakistone, B. A., Swaisgood, H. E., & Horton, H. R. (1981) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(81)90427-6 · Cited by 61
Properties of the xanthine oxidase from human liver
Corte, E. D., Gozzetti, G., Novello, F., & Stirpe, F. (1969) · Biochimica et Biophysica Acta (BBA) - Enzymology · doi:10.1016/0005-2744(69)90327-1 · Cited by 60 · cited 1×
“Based on its levels of mRNA and protein expression, the highest activity levels of human XOR are present in the intestine [50,51] and liver [52–54], while a very low activity has been detected in other human organs [55,56].”
BackgroundUse of Melatonin to Prevent Selenite-Induced Cataract Formation in Rat Eyes
Yağcı, R., Aydın, B., Erdurmuş, M., Karadağ, R., Gürel, A., Durmuş, M., & Yiğitoğlu, R. (2006) · Current Eye Research · doi:10.1080/02713680600899663 · Cited by 60 · cited 1×
“role of XOR-produced ROS in this model of eye damage [169].”
BackgroundReiners, J. J., Pence, B. C., Barcus, M. C. S., & Cantú, A. R. (1987) · PubMed · Cited by 59
Xanthine Oxidoreductase Gene Expression and Enzyme Activity in Developing Human Tissues
Saksela, M., Lapatto, R., & Raivio, K. O. (1998) · Neonatology · doi:10.1159/000014034 · Cited by 59 · cited 1×
“, liver and intestine inmice [44] and humans [45].”
BackgroundIntermediate dehydrogenase-oxidase form of xanthine oxidoreductase in rat liver
Kamiński, Z., & Jeżewska, M. (1979) · Biochemical Journal · doi:10.1042/bj1810177 · Cited by 59 · cited 16×
“The main molecular sources of such oxidants in endothelial cells have been identified in NAD(P)H oxidase, xanthine oxidase, and NO synthase, which are involved in the dysregulation of the vascular redox environment that is associated with impaired vascular function and cardiovascular diseases (reviewed in [290]).”
BackgroundInfluentialThe regulation of rat‐liver xanthine oxidase: Activation by proteolytic enzymes
Corte, E. D., & Stirpe, F. (1968) · FEBS Letters · doi:10.1016/0014-5793(68)80107-3 · Cited by 57 · cited 2×
“(reviewed in [3]) until almost half a century ago, when mammalian XOR was shown to be a dehydrogenase in its native state [40,41].”
BackgroundNewaz, M., Yousefipour, Z., & Oyekan, A. (2006) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000245402.62864.0a · Cited by 57 · cited 1×
“In aging rats, the increased ROS-associated elevation of systolic blood pressure appeared to be dependent on vascular XOR but not on NAD(P)H oxidase activity [291].”
BackgroundAluminium increases xanthine oxidase activity and disturbs antioxidant status in the rat
Moumen, R., Aít-Oukhatar, N., Bureau, F., Fleury, C., Bouglé, D. L., Arhan, P., Neuville, D., & Viader, F. (2001) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/s0946-672x(01)80049-3 · Cited by 57 · cited 1×
“Hepatic damage caused by a variety of toxic agents was associated with elevated serum XOR levels, particularly after treatment with CCl4 or thioacetamide in sheep [161] and after treatment with CCl4 [162, 163], colchicine [164], halothane [165], ethanol [166], saporin [130] or aluminium [167] in rats.”
BackgroundNicholas, S. A., Bubnov, V. V., Yasinska, I. M., & Sumbayev, V. V. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0450-3 · Cited by 57
MODIFICATION OF OXIDATIVE STRESS IN RESPONSE TO INTESTINAL PRECONDITIONING1
Solà, A., Hotter, G., Prats, N., Xaus, C., Gelpı́, E., & Roselló‐Catafau, J. (2000) · Transplantation · doi:10.1097/00007890-200003150-00016 · Cited by 57 · cited 1×
“to pre-conditioning procedures [152].”
Sabán-Ruiz, J., Alonso-Pacho, A., Fabregate, M., & Gonzalez-Quevedo, C. D. L. P. (2013) · Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry · doi:10.2174/1871523011312010011 · Cited by 56
Karabulut, A. B., Kafkaslı, A., Burak, F., & Gözükara, E. M. (2004) · Cell Biochemistry and Function · doi:10.1002/cbf.1152 · Cited by 56
Determination of human plasma xanthine oxidase activity by high-performance liquid chromatography
Yamamoto, T., Moriwaki, Y., Takahashi, S., Tsutsumi, Z., Yamakita, J.-I., Nasako, Y., Hiroishi, K., & Higashino, K. (1996) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/0378-4347(96)00071-0 · Cited by 55 · cited 1×
“The detection of XOR in tissues and fluids containing low levels of XOR requires particularly sensitive assays, such as radiometry [59,60], fluorometry [61,62], HPLC [63], enzyme immunoassays, and immunohistochemistry [64–66].”
MethodKögler, H. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00512-1 · Cited by 53 · cited 1×
“XOR activity level, which was more pronounced in failing rat myocardium [255].”
BackgroundRole of oxygen radicals in tourniquet-related ischemia-reperfusion injury of human patients
Friedl, H. P., Till, G. O., Trentz, O., & Ward, P. A. (1991) · Journal of Molecular Medicine · doi:10.1007/bf01645168 · Cited by 53
Uric Acid, Heart Failure Survival, and the Impact of Xanthine Oxidase Inhibition
Harzand, A., Tamariz, L. J., & Hare, J. M. (2011) · Congestive Heart Failure · doi:10.1111/j.1751-7133.2011.00262.x · Cited by 53
Allopurinol Treatment Reduces Arterial Wave Reflection in Stroke Survivors
Khan, F., Casella, G., Wong, K., McSwiggan, S., Struthers, A. D., & Belch, J. J. F. (2008) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2008.00057.x · Cited by 52 · cited 1×
“arterial wave reflection as a measure of vascular function [262].”
BackgroundGibbings, S. L., Elkins, N. D., Fitzgerald, H., Tiao, J., Weyman, M. E., Shibao, G. N., Fini, M. A., & Wright, R. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.150847 · Cited by 52
Sultatos, L. G. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22210-8 · Cited by 52 · cited 1×
“The increase of ROS-producing enzyme forms has been reported in burn injury [121]; haematoporphyrin derivative-mediated cutaneous photosensitisation [122]; in vivo and in vitro ethanol intoxication [119,123,124]; glutathione depletion [125]; endothelial”
BackgroundGastric intramucosal pH and multiple organ injury
Nielsen, V. G., Tan, S., Baird, M. S., McCammon, A. T., & Parks, D. A. (1996) · Critical Care Medicine · doi:10.1097/00003246-199608000-00012 · Cited by 51 · cited 1×
“protective towards the decrease of gastric intramucosal pH induced by hepatoenteric ischaemia/reperfusion, which is considered a marker of multiple organ injury [185].”
BackgroundMüller, M. J., Vollmar, B., Friedl, H.-P., & Menger, M. D. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(96)00028-7 · Cited by 51
Liver xanthine dehydrogenase and iron mobilization
Topham, R. W., Walker, M. C., & Calisch, M. P. (1982) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(82)91910-6 · Cited by 50 · cited 1×
“In addition to cytotoxicity and tissue damage, XOR-generated ROS are responsible for many biological activities, including iron mobilisation from ferritin in the liver [17], iron absorption in the intestinal mucosal [18], and the induction of proliferation [19–21] as”
BackgroundSegal, B. H., Sakamoto, N., Patel, M. B., Maemura, K., Klein, A. S., Holland, S. M., & Bulkley, G. B. (2000) · Infection and Immunity · doi:10.1128/iai.68.4.2374-2378.2000 · Cited by 50
Kooij, A., Schijns, M., Frederiks, W. M., Noorden, C. J. F., & James, J. (1993) · Virchows Archiv B Cell Pathology Including Molecular Pathology · doi:10.1007/bf02899240 · Cited by 49 · cited 2×
“as well as with intracellular organelles, such as peroxisomes [48] (reviewed in [49]).”
BackgroundMaia, L. B., Duarte, R. O., Freire, A. P., Moura, J. J. G., & Mira, L. (2007) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-007-0229-7 · Cited by 49 · cited 1×
“The bactericidal activity of XOR may be potentiated either by the possibility to act as an NADH oxidase [29–31] or by the ability to produce peroxynitrite [32].”
BackgroundBattelli, M. G., Abbondanza, A., & Stirpe, F. (1992) · Chemico-Biological Interactions · doi:10.1016/0009-2797(92)90093-z · Cited by 47
Self-citationShafik, A. N. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2391-1 · Cited by 47 · cited 1×
“mesenteric artery ligation in rats led to an elevation in XOR serum levels, and XOR activity inhibition with febuxostat reduced the degree of local intestinal injury and the consequent remote hepatic and lung impairment [239].”
Backgroundde GROOT, H., & Littauer, A. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)81080-5 · Cited by 46 · cited 1×
“Furthermore, XOR was released from the severely injured cells before the XDH/XO conversion occurred [145].”
BackgroundXanthine oxidase mediates myocardial injury after hepatoenteric ischemia-reperfusion
Nielsen, V. G., Tan, S., Baird, M. S., Samuelson, P. N., McCammon, A. T., & Parks, D. A. (1997) · Critical Care Medicine · doi:10.1097/00003246-199706000-00023 · Cited by 46
Xanthine oxidoreductase release after descending thoracic aorta occlusion and reperfusion in rabbits
Nielsen, V. G., Weinbroum, A., Tan, S., Samuelson, P. N., Gelman, S., & Parks, D. A. (1994) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(94)70041-9 · Cited by 45 · cited 1×
“elevation after artery ligation in cats [181], rabbits [182–186], and rats [27,157,187,188] as well as after haemorrhagic shock in mice [26] and”
BackgroundLung injury and complement activation: Role of neutrophils and xanthine oxidase
Till, G. O., Friedl, H. P., & Ward, P. A. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90046-6 · Cited by 45 · cited 1×
“increase of XOR activity in plasma,whichwas partially related to the appearance of histamine in plasma [168].”
BackgroundCloning and expression in vitro of human xanthine dehydrogenase/oxidase
Saksela, M., & Raivio, K. O. (1996) · Biochemical Journal · doi:10.1042/bj3150235 · Cited by 45 · cited 1×
“in vitro [68–70].”
Wakabayashi, Y., Fujita, H., Morita, I., Kawaguchi, H., & Murota, S. (1995) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(94)00202-p · Cited by 44 · cited 1×
“stimulation with C5a, TNF, a chemotactic N-formyl peptide [126] or activated neutrophils [127,128]; kainic acid [60] or glutamate neurotoxicity [129]; ricin hepatotoxicity [130]; in a rat model of nephropathy [131]; ultraviolet B radiation [132]; irradiation with gamma rays [133]; hepatocellular injury induced by iron…”
Background
Research works printed but not linked: 1
- Nguyen, 1986, Plant xanthine dehydrogenase: its distribution, properties and function, Physiol. Vég., 24, 263
Cited by
Sorted by citations
Sharifi-Rad, M., Anil Kumar, N. V., Zucca, P., Varoni, E. M., Dini, L., Panzarini, E., Rajkovic, J., Tsouh Fokou, P. V., Azzini, E., Peluso, I., et al. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00694 · Cited by 1,971
Self-citationReperfusion injury and reactive oxygen species: The evolution of a concept
Granger, D. N., & Kvietys, P. R. (2015) · Redox Biology · doi:10.1016/j.redox.2015.08.020 · Cited by 1,550
“The binding of circulating XO to vascular endothelial cells has been invoked to explain the effectiveness of xanthine oxidase inhibitors in blunting the I/R injury response in tissues that exhibit low XO activity [131].”
BackgroundIncalza, M. A., D’Oria, R., Natalicchio, A., Perrini, S., Laviola, L., & Giorgino, F. (2017) · Vascular Pharmacology · doi:10.1016/j.vph.2017.05.005 · Cited by 1,419
“Finally, it should be mentioned that under specific pathological conditions, such as liver and intestine diseases [80] and hypoxia [81], XDH is released to the circulation and converted to the XO form that binds to”
BackgroundClinical Relevance of Biomarkers of Oxidative Stress
Frijhoff, J., Winyard, P. G., Žarković, N., Davies, S. S., Stocker, R., Cheng, D., Knight, A. R., Taylor, E., Oettrich, J., Ruskovska, T., et al. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6317 · Cited by 918
“This led to several, ongoing clinical trials with XO inhibitors in CVD and prompted many studies to measure circulating XO (12).”
ResultSources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation
Tejero, J., Shiva, S., & Gladwin, M. T. (2019) · Physiological Reviews · doi:10.1152/physrev.00036.2017 · Cited by 541
Metadata
- Authors
- Battelli, M. G., Bolognesi, A., & Polito, L.
- Affiliations
- University of Bologna (IT)
- Corresponding author
- Bolognesi, Andrea
- Polito, Letizia
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Publisher
- Elsevier BV
- Published
- 2014-09
- Volume
- 1842
- Issue
- 9
- Pages
- 1502-1517
- ISSN
- 0925-4439 (ISSN-L)
- OpenAlex
- W2073007450
- Cited by
- 256
- References
- 308
- Citations by year
- 2026: 15 · 2025: 10 · 2024: 23 · 2023: 29 · 2022: 20 · 2021: 30 · 2020: 30 · 2019: 24 · 2018: 20 · 2017: 21 · 2016: 16 · 2015: 17 · 2014: 1
- FWCI
- 2.66
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, cc-by-nc-nd)
- Funders
- Alma Mater Studiorum‐University of Bologna
- Pallotti Legacies for Cancer Research
- Topics
- Health Sciences › Medicine › Nephrology › Gout, Hyperuricemia, Uric Acid
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Keywords
- xanthine oxidoreductase, purine degradation, uric acid, oxidative stress, reactive oxygen species, endothelial cells, vascular response, inflammation, thrombosis, cardiovascular disease, metabolic disorders, serum enzyme levels
- MeSH terms
- Animals, Cardiovascular Diseases, Humans, Xanthine Dehydrogenase, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review